CP
This startup develops an integrated, end-to-end continuous manufacturing process for pharmaceuticals, transforming raw materials into final drug products. Their technology aims to reduce production costs and increase efficiency for pharmaceutical companies.
Updated 16 months ago
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MB
Funding rounds are not available yet.
Founders
Product
Features
- This startup develops an integrated, end-to-end continuous manufacturing process for pharmaceuticals, transforming raw materials into final drug products. Their technology aims to reduce production costs and increase efficiency for pharmaceutical companies.